|
Exchange Received Time  07/12/2019 16:37:35 Exchange Disseminated Time 07/12/2019 16:37:49 Time Taken 00:00:14 | In compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015, we wish to inform that the meeting of Board of Directors of Lincoln Pharmaceuticals Limited (the "Company") held on today, i.e. December 7, 2019 and considered and decided following business; 1. It is decided to withdraw the Scheme of amalgamation between Lincoln Parenteral Limited ("Transferor Company") and Lincoln Pharmaceuticals Limited ("Transferee Company") as approved by the Board of Directors in its meeting held on September 19, 2019 and 2. Approved the Scheme of Amalgamation between Lincoln Parenteral Limited ("Transferor Company") and Lincoln Pharmaceuticals Limited ("Transferee Company") ("Scheme"), subject to all requisite approval. The Appointed Date for the Scheme is April 01, 2019. |
|
|